Peter Dove
Impact in
-
- Acute Myocardial Infarction Research
- Heart Failure Treatment and Management
- Cardiac electrophysiology and arrhythmias
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiovascular Function and Risk Factors
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Nitric Oxide and Endothelin Effects 5
-
- Electron Spin Resonance Studies 2
- Co-authors
- Frank Porreca (5 shared papers)Jailall Ramnauth (5 shared papers)Suman Rakhit (5 shared papers)Shawn P. Maddaford (5 shared papers)John S. Andrews (5 shared papers)Gabriela Mladenova (4 shared papers)András Sándor (1 shared paper)Marvin E. Rosenthale (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (3 papers)The Lancet (2 papers)Toxicology and Applied Pharmacology (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- United StatesCanadaSlovenia
In The Last Decade
Peter Dove
11 papers receiving 1.7k citations
Peter Dove's Hit Papers
Peers
Comparison fields: 5 of 103
- Cardiology and Cardiovascular Medicine 1.1k
- Internal Medicine 152
- Radiology, Nuclear Medicine and Imaging 288
- Statistics, Probability and Uncertainty 86
- Emergency Medicine 81
Countries citing papers authored by Peter Dove
This map shows the geographic impact of Peter Dove's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Dove with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Dove more than expected).
Fields of papers citing papers by Peter Dove
This network shows the impact of papers produced by Peter Dove. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Dove. The network helps show where Peter Dove may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Dove, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | ISIS-4 - A randomised factorial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58.050 patient with suspected acute myocardial-infarction. Hit paper breakdown → | 1995 | 966 |
| 2 | ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION Hit paper breakdown → | 1992 | 757 |
| 3 | 2011 | 37 | |
| 4 | 2011 | 31 | |
| 5 | 1977 | 28 | |
| 6 | 2012 | 17 | |
| 7 | 2012 | 14 | |
| 8 | 2005 | 11 | |
| 9 | 2012 | 8 | |
| 10 | 2015 | 3 | |
| 11 | Structural modification of H2-receptor antagonists provide post-H2-receptor gastric antisecretory activity. | 1987 | 3 |
| 12 | 2015 | 0 |
About Peter Dove
Peter Dove is a scholar working on Physiology, Biophysics, Biochemistry, Hematology and Molecular Biology, having authored 12 papers that have together received 1.9k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (5 papers), Pharmacological Receptor Mechanisms and Effects (2 papers), Electron Spin Resonance Studies (2 papers), Protein Degradation and Inhibitors (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Multiple Myeloma Research and Treatments (2 papers), Heart Failure Treatment and Management (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.1k citations), Internal Medicine (152 citations), Radiology, Nuclear Medicine and Imaging (288 citations), Statistics, Probability and Uncertainty (86 citations) and Emergency Medicine (81 citations). Peter Dove has collaborated with scholars based in United States, Canada and Slovenia. Frequent co-authors include Frank Porreca, Jailall Ramnauth, Suman Rakhit, Shawn P. Maddaford, John S. Andrews, Gabriela Mladenova, András Sándor, Marvin E. Rosenthale, Milena De Felice and David K.H. Lee. Their work appears in journals such as Journal of Medicinal Chemistry, The Lancet, Toxicology and Applied Pharmacology, Bioorganic & Medicinal Chemistry Letters and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.